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Abstract
In the nucleus of HIV-1 infected cells, unintegrated HIV-1 DNA molecules exist in the form of one and two LTR circles and
linear molecules with degraded extremities. In tissue culture they are invariably more numerous than the provirus, the
relative proportion of integrated to unintegrated forms varies widely from ,1:1 to 1:10 and even over 1:100. In vivo, this
ratio is unknown. To determine it, single nuclei from two infected patients with a known provirus copy number were
microdissected, HIV DNA was amplified by nested PCR, cloned and individual clones sequenced. Given the extraordinary
sequence complexity, we made the assumption that the total number of distinct sequences approximated to real number
of amplifiable HIV-1 DNA templates in the nucleus. We found that the number of unintegrated DNA molecules increased
linearly with the proviral copy number there being on average 86 unintegrated molecules per provirus.
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Introduction
The phenomenal intrapatient variation of human immunode-
ficiency virus type 1 (HIV-1) genome needs no introduction
[1,2,3,4,5,6,7]. The absence of proofreading mechanisms associ-
ated with the reverse transcriptase, the high recombination rate
and high turnover are the main factors [8,9,10]. Whenever
multiple infections occur, recombination invariably follows.
Recombination is present at all levels of HIV genetics [11,12].
Within an infected individual recombinant genomes show up in
network analyses of HIV sequences [13,14,15,16]. In an animal
model, macaques inoculated simultaneously with SIVmac239Dvpx
or Dvpr and with SIVmac239Dnef, the emergence of wild-type
virus was detected in blood in as little as 2 weeks post-inoculation
[17,18]. Finally, some strains in widespread circulation are clearly
composites of at least 2–3 other clades [19,20,21,22].
Recently, it was shown that in infected patients ,85% of
infected CD4
+ T cells in blood contain only one copy of HIV-1
DNA [23]. This would suggest a limited potential for recombi-
nation in virus produced by these cells. However, HIV replicates
mainly in secondary lymphoid organs. The spleen is a secondary
lymphoid organ replete with white pulps and germinal centres and
it is in such structures that HIV recombination will occur. Indeed,
the majority of HIV-1 infected cells in vivo harbour multiple
proviruses and additional unintegrated DNA molecules [4,5], the
average proviral copy number per infected cell being 3–4 with
a range of 1–8 [5]. Greater than 75% of infected cells harboured
two or more proviruses [5]. The ratio of unintegrated/provirus
DNA molecules was not addressed [5]. It is well known that
proviruses are accompanied by unintegrated DNA forms, either as
covalently closed circles with one or two LTRs or linear molecules
with ends degraded by exonucleases [24,25,26,27]. In tissue
culture experiments the relative proportion of integrated to
unintegrated forms varies widely from ,1:1 to 1:10 and even
over 1:100 [28,29].
How can this ratio be addressed for single cells in vivo?
Fluorescence in situ hybridization (FISH) can quantify the number
of proviruses per cell [5]. In this work, Jung et al., reported
extensive genetic variability within the hypervariable V1V2 region
of viruses from two patients. Indeed, the vast majority of sequences
were unique. This is perhaps not too surprising as the hypervari-
able V1V2 region of env is one of the most variable regions of the
HIV-1 genome and thus offers the greatest resolution. This choice
also meant there was no interference from the HIV-1Denv probe
used for FISH [5]. Given the phenomenal variation for these two
patients, it is probably a reasonable assumption to equate the
number of unique sequences with total number of distinct
molecules within the nucleus. Accordingly, if sequencing was
performed on the nuclei of single cells, it is possible to estimate the
number of unintegrated DNA copies per nucleus.
Materials and Methods
Patients/Ethics Approval
The two patients, B and R, have been already described
[1,4,5,30]. Briefly, patient B was at stage clinical B1 and had
a blood CD4 count of 583/ml and a plasma viremia titre of 5,900
RNA copies/ml. Patient R was at stage C2, while the blood CD4
count and viremia were 317/ml and 126,000 RNA copies/ml
respectively. Splenic tissues from patients B and R came from
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the two patients have been obtained from Ho ˆpital Saint-Louis
(Paris, France). Informed consent were obtained from the patients
B and R.
Preparation of Cells for Fluorescence In situ Hybridization
Frozen spleen cells from HIV-infected patients were thawed
and stimulated with 2.5 mg/ml phythaemagglutinin (PHA)
(Difko, Detroit, MI. USA) in the presence of 10 mM azidothy-
midine (AZT) (Sigma, Taufkirchen, Germany) to prevent the
virus spread in the cell culture [1,4,5,30]. After two days of
culture in RPMI 1640 (Lonza, Velviers, Belgium) with 10% fetal
calf serum (Invitrogen, Karlsruhe, Germany), 1% penicillin/
streptomycin (Biochrom AG, Berlin, Germany) and IL-2 (100 U/
ml; Chiron Behring, Marburg, Germany), the cell nuclei were
prepared via incubation with 0.1 M KCl for 30 min at 37uC,
fixed with methanol/acetic acid 3:1 at 4uC and stored at 220uC.
The HIV FISH was performed according to our previous HIV
protocol [5]. Nuclei with defined HIV provirus numbers were
microdissected using a PALM Robot16 MicroBeam, according
to the manufacturer’s instructions (PALM Bernried, Germany),
and transferred to PCR tubes with the laser pressure catapulting
technique.
PCR Amplification, Cloning and Sequencing
A fragment of the HIV envelope genome (V1V2) was amplified
employing a semi-nested procedure. In order to increase sensitivity
and specificity, hot start PCR was performed. First round
primers were LV15 59- gccacacatgcctgtgtacccaca and LV13 59-
CTTTAGAATGCGAAAACCAGCCG while primers SK122
and SK123 59-CTAAAGCCATGTGTAAATTAACC and 59-
TGGCTCAAAGGATACCTTTGGACA were used for the
second round. The first and second round of PCR involved
standard amplification, the reaction parameters were 95uC for
5 min, followed by 35 cycles (95uC for 30 s, 55uC for 30 s, and
72uC for 30 s) and finally for 10 min at 72uC. The buffer
conditions were 2.5 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl
(pH 8.3), 200 mM of each dNTP, 100 mM of each primer, and 2.5
units of Taq DNA polymerase (Cetus) in a final volume of 50 ml.
The equivalent of 0.2 l of the first round reaction is used as
template in the second round. Amplification products were
purified from agarose (Qiaex II kit, Qiagen, France) and directly
cloned into the pCR2.1-TOPO vector included in the TOPO TA
Cloning Kit (Invitrogen Corp., San Diego, CA). After trans-
formation of E. coli TOP10F’ Blue cells, up to 4000 clones were
picked and sequenced by GATC Biotech.
Determination of PCR-mediated Recombination
Frequency
To appreciate the PCR-mediated recombination frequency, ten
picograms each of DNA corresponding to V1V2 mini-prep clones
01 and 16 were mixed and subjected to 35 cycles of PCR with
primers L1 and L2 and 1/10 of the first PCR was used to amplify
for 35 cycles with primers SK122 and SK123 under the same
conditions as those described above [2,5,31]. The DNA was
purified and cloned into TOPO TA cloning site. About 500
colonies were screened with 4 different
32P-labeled oligonucleo-
tides (Probes A1 59 AACACCAATAATAGTAGCAA and A2 59
TGATACTTCTAGCTATAGC for clone 01 and B1 59
GTGCACTAATAATAACACC and B2 59 TATAGGAAATGA-
TACTACTA for clone 16, data not shown). Plaques giving
positive hybridization signals with both couple of primers A1+B2
or/and B1+A2 were considered PCR-mediated recombinants.
Recombination was confirmed by sequencing and a recombination
frequency of 2/500 or ,4610
23 established.
Results
Quantification of Unintegrated HIV-1 DNA
For sequencing, how many molecules should be sequenced to
detect the real number of distinct viral DNA in a sample? We
considered P, the probability of finding a new sequence, and N as
the absolute number of distinct sequences, while x and y are the
number of total and unique sequences experimentally determined
respectively. The relationship between P and N is obtained from
the equation, P=(N2y)/N (Figure 1). For an x/y ratio ,2
approximately 80% of unique sequences (y) can be identified.
HIV-positive interphase nuclei from two patients (B and R) were
laser microdissected and transferred to PCR tubes and the V1V2
env region amplified. In order to increase sensitivity and specificity,
hot start PCR was performed. Four splenocytes from patient R
harbouring a single provirus constituted the starting point
(Figure 2). Small numbers of sequences were sufficient for the
number of unique sequences (y) to plateau. The values of y ranged
from 12–14 to 39, which translates into values of N of 13–16 and
42 respectively (Figures 2). Given the underlying assumption that
all genomes are genetically unique, the unintegrated/provirus
ratios are $13:1 to 42:1.
A similar analysis was performed on the nuclei of six splenocytes
with 2 or 6 proviruses from patient B (Figures 3A and 4A). The
number of unique sequences identified ranged from 131 to 172 for
cells harbouring 2 proviruses, and between 359 and 677 for those
with 6 proviruses (Figure 4A). Values of N ranged from 150–927,
while the unintegrated DNA/provirus ratios (Z) were of the order
of 75–155 (Figure 4A). Approximately 927 unique HIV genomes
were predicted for nucleus B06 (Figures 3A and 4A). A selection of
V1V2 protein sequences from B06 is shown in Figure 3B,
a number of which are arguably recombinants. Most probably if
more sequences from other cells were sequenced it would be
possible to identify more recombinants. Indeed, given the
Figure 1. Relationship between the probability P of scoring for
a new sequence as a function of the ratio of genetically distinct
(y) and total (x) sequences.
doi:10.1371/journal.pone.0036246.g001
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infected splenocytes for patient B, probably all sequences were
recombined in a relatively recent time frame. Recombination was
confirmed by sequencing and a recombination frequency of 2/500
or ,4610
23 established. In parallel, Taq polymerase mutation
frequency was shown to be f ,10
25, suggesting that the high
mutation frequency observed was not associated to Taq poly-
merase.
G to A Hypermutation at a Single Cell Level
The B6 nucleus also harboured two G-.A hypermutated
sequences which were interesting. Such genomes are associated
with editing by host cell cytidine deaminases APOBEC3F and 3G
in the context of a Dvif genotype. The enzymes show distinct
dinucleotide contexts associated with editing, notably TpC.CpC
for APOBEC3F and CpC.TpC for APOBEC3G, where the
edited base is underlined [32,33,34,35,36,37]. The two sequences
showed remarkable selectivity for dinucleotide editing context. For
clone 06 TpC was very strongly preferred over CpC, while for
clone 79 the opposite was apparent (Figure 3C). These striking
differences suggest that occasionally only A3F or A3G are
packaged, which is feasible given the estimations of low levels
packaged into virions [38]. Presumably hypermutated genomes
with less startling biases probably reflect co-packaging of both
APOBEC3 proteins.
Discussion
For these two patients, proviruses are accompanied by a very
large number of unintegrated forms, varying from Z=13–155
molecules per provirus (Figure 4A). As only 10 nuclei were
analysed (4 from patient R +6 from B), this number is by no
means a maximum. Interestingly the relationship between N
and pv is linear (Figure 4B). While the sample size of this
present study is low and thus has limited statistical power, the
results obtained for the patients are similar. Given these large
values for Z, it is logical that many splenocytes harbour
unintegrated DNA alone. As the present study focussed on cells
with FISH-positive proviruses such cells were not scored. While
the values for Z are large compared to those derived from tissue
culture, a recent report in a very different setting, peripheral
blood mononuclear cells from HIV-infected Elite suppressors
identified an unintegrated/integrated DNA ratios of between
10/1 to up to 10,000/1 [39].
Figure 2. Quantification of genetically distinct HIV-1 V1V2 Env sequences within four splenocytes from patient R harbouring
a single HIV-1 provirus.
doi:10.1371/journal.pone.0036246.g002
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molecules found in different nuclei indicates that the source of
virus infection was very complex. Within an established HIV-
infected patient there are three sources of genetically complex
virus. These are circulating virus, virus on follicular dendritic cells
(FDC) and virus associated with dendritic cells (DC) presented to
CD4+ T lymphocytes. As the infection frequency of splenocytes
was ,1%, this rules out circulating virus, as the major source. The
virus on FDC surfaces is essentially in the form of immune
complexes and is mainly presented to B cells [40]. By contrast DCs
present very efficiently HIV to CD4+ T lymphocytes [41]. While
the present data cannot distinguish between the FDC and DC
sources, the cellular immunology of DCs pleads in favour of the
latter.
Using cell free virus to infect cells ex vivo, treatment of the target
cell by proteasome inhibitors enhances viral growth ,3 fold
indicating that more viruses infect and enter a cell than make it to
the nucleus [42]. Assuming a comparable phenomenon in vivo the
number of virions needed to infect a single splenocyte would be of
the order of 40–2800. If other catabolic pathways were operative,
the number of virions would necessarily be even greater.
Infection of a single cell by many virions could well be a general
phenomenon in virology. However, in order to quantify the
number of incoming virions some trait is needed to distinguish
them from the replication template for progeny virus. For
retroviruses the incoming genome is RNA while the template for
transcription is DNA. For RNA viruses, such as poliovirus, there is
no such trait distinguishing parent and daughter genomes. Of
course recombinants are a tell tale sign. Following vaccination
with the three attenuated polioviruses, recombinants among them
have been described, as have recombinants between vaccinating
strains and wild type poliovirus and other enteroviruses [43,44].
Although negative stranded viruses such as influenza are known to
recombine rarely, recombinants can be identified [45]. Along with
the above data such examples indicate that multi-infection is
probably commonplace, an inevitable consequence of the capacity
of a cell to produce hundreds to thousands of virions in a very
small space.
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